Literature DB >> 22077658

Anxiety and depression in obese and normal-weight individuals with diabetes type 2: a gender perspective.

Irene Svenningsson1, Cecilia Björkelund, Bertil Marklund, Birgitta Gedda.   

Abstract

BACKGROUND: Obesity is a problem that is increasing worldwide, leading to an increased incidence of type 2 diabetes mellitus (T2DM). Depression is more common among individuals with diabetes, and they are more likely than non-diabetic individuals to experience emotional problems. People with both T2DM and obesity bear an additional emotional burden, which affects their quality of life.
OBJECTIVES: To describe the prevalence of symptoms of anxiety and depression in groups of obese and normal-weight individuals with T2DM who are undergoing primary care and to investigate possible differences between the groups and between genders.
METHOD: Three hundred and thirty-nine patients with T2DM from nine primary-care centres participated in a cross-sectional study (n = 180 + 159). The response rate was 67%. The Hospital Anxiety and Depression Scale (HADS) and the Beck Depression Inventory - second edition (BDI-II) were employed to estimate the patients' symptoms of depression and anxiety.
RESULTS: An association between T2DM, obesity and depression was observed in both genders. More than one in three women and one in five men with T2DM and obesity exhibited symptoms of anxiety or depression. In the normal-weight group, the females presented more symptoms of anxiety than did their male counterparts.
CONCLUSION: In primary healthcare, the fact that both obese men and women with T2DM are at increased risk of anxiety and depression is an important finding, which must be recognised and considered in the course of primary healthcare consultations. Meeting the unique needs of each individual requires an understanding of both laboratory data and the individual's emotional status.
© 2011 The Authors. Scandinavian Journal of Caring Sciences © 2011 Nordic College of Caring Science.

Entities:  

Mesh:

Year:  2011        PMID: 22077658     DOI: 10.1111/j.1471-6712.2011.00940.x

Source DB:  PubMed          Journal:  Scand J Caring Sci        ISSN: 0283-9318


  12 in total

1.  Lifestyle changes - a continuous, inner struggle for women with type 2 diabetes: a qualitative study.

Authors:  Kristina Ahlin; Annika Billhult
Journal:  Scand J Prim Health Care       Date:  2012-02-12       Impact factor: 2.581

2.  Relationship of negative affect and outcome of an opioid therapy trial among low back pain patients.

Authors:  Robert N Jamison; Robert R Edwards; Xiaoxia Liu; Edgar L Ross; Edward Michna; Meredith Warnick; Ajay D Wasan
Journal:  Pain Pract       Date:  2012-06-11       Impact factor: 3.183

3.  Association between obesity and depression in patients with diabetes mellitus type 2; a study protocol.

Authors:  Eduardo De la Cruz-Cano; Carlos Alfonso Tovilla-Zarate; Emilio Reyes-Ramos; Thelma Beatriz Gonzalez-Castro; Isela Juarez-Castro; Maria Lilia López-Narváez; Ana Fresan
Journal:  F1000Res       Date:  2015-01-09

Review 4.  Sex differences in type 2 diabetes: focus on disease course and outcomes.

Authors:  Lisa Arnetz; Neda Rajamand Ekberg; Michael Alvarsson
Journal:  Diabetes Metab Syndr Obes       Date:  2014-09-16       Impact factor: 3.168

5.  Gut microbiota modulate neurobehavior through changes in brain insulin sensitivity and metabolism.

Authors:  Marion Soto; Clémence Herzog; Julian A Pacheco; Shiho Fujisaka; Kevin Bullock; Clary B Clish; C Ronald Kahn
Journal:  Mol Psychiatry       Date:  2018-06-18       Impact factor: 15.992

Review 6.  Insulin Resistance as a Shared Pathogenic Mechanism Between Depression and Type 2 Diabetes.

Authors:  Natalia de M Lyra E Silva; Minh P Lam; Claudio N Soares; Douglas P Munoz; Roumen Milev; Fernanda G De Felice
Journal:  Front Psychiatry       Date:  2019-02-14       Impact factor: 4.157

7.  Sex-related illness perception and self-management of a Thai type 2 diabetes population: a cross-sectional descriptive design.

Authors:  Wimonrut Boonsatean; Anna Carlsson; Irena Dychawy Rosner; Margareta Östman
Journal:  BMC Endocr Disord       Date:  2018-01-30       Impact factor: 2.763

8.  Evaluation of a multiprofessional, nonsurgical obesity treatment program: which parameters indicated life style changes and weight loss?

Authors:  Roland Müller; Markus Laimer; Niels Hagenbuch; Kurt Laederach; Zeno Stanga
Journal:  J Eat Disord       Date:  2017-05-15

9.  Examining the risk of depression or self-harm associated with incretin-based therapies used to manage hyperglycaemia in patients with type 2 diabetes: a cohort study using the UK Clinical Practice Research Datalink.

Authors:  John-Michael Gamble; Eugene Chibrikov; William K Midodzi; Laurie K Twells; Sumit R Majumdar
Journal:  BMJ Open       Date:  2018-10-08       Impact factor: 2.692

10.  Ubiquitin fold modifier 1 activates NF-κB pathway by down-regulating LZAP expression in the macrophage of diabetic mouse model.

Authors:  Xiaolei Hu; Hengyan Zhang; Yuan Song; Langen Zhuang; Qingqing Yang; Minglin Pan; Fengling Chen
Journal:  Biosci Rep       Date:  2020-01-31       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.